20/12/2019 | Notice of Change in Substantial Holding – Section 671B |
29/11/2019 | AGM 2019 – Chairman’s Address |
29/11/2019 | Results of Annual General Meeting |
25/10/2019 | Notice of Annual General Meeting – Proxy Form |
14/10/2019 | Notice of Initial Substantial Holder – Section 671B |
11/10/2019 | Notice of Ceasing to be a Substantial Holder |
07/10/2019 | Notice of Initial Substantial Holder |
02/10/2019 | Notice of Ceasing to be a Substantial Holder |
12/09/2019 | Rhinomed Shares Commence Trading in the USA on the OTCQB Market |
19/09/2019 | Rhinomed Trading Halt |
12/09/2019 | Rhinomed Shares Commence Trading in the USA on the OTCQB Market |
04/09/2019 | Change of Address |
15/07/2019 | New Pronto Rechargeable Vapour Release Technology Receives CE Mark |
11/07/2019 | Mute the Fastest Growing Product in Category in US |
02/07/2019 | Notice of Change of Interests of Substantial Holder |
28/06/2019 | Rhinomed Supports Study Examining Link Between Sleep and Suicide |
17/05/2019 | New Pronto Rechargeable, Vapour Release Technology Registered with US FDA and Australian TGA |
06/05/2019 | Notice of Change of Interest of Substantial Holder |
15/04/2019 | Rhinomed to Launch Revolutionary New Rechargeable, Vapour Release Technology Targeting Sleep and Decongestion |
28/03/2019 | Notice of Change of Interests of Substantial Holder |
01/03/2019 | Notice of Change of Interests of Substantial Holder |
03/01/2019 | Change of Director’s Interest Notice |